Equities Analysts Issue Forecasts for BBWI Q3 Earnings

Bath & Body Works, Inc. (NYSE:BBWI - Free Report) - Analysts at Telsey Advisory Group reduced their Q3 2026 EPS estimates for Bath & Body Works in a research report issued to clients and investors on Tuesday, May 20th. Telsey Advisory Group analyst D. Telsey now anticipates that the company will post earnings per share of $0.50 for the quarter, down from their prior forecast of $0.54. Telsey Advisory Group has a "Outperform" rating and a $43.00 price objective on the stock. The consensus estimate for Bath & Body Works' current full-year earnings is $3.30 per share. Telsey Advisory Group also issued estimates for Bath & Body Works' Q1 2027 earnings at $0.59 EPS, Q2 2027 earnings at $0.48 EPS, Q3 2027 earnings at $0.57 EPS and Q4 2027 earnings at $2.32 EPS.

Several other equities analysts have also issued reports on BBWI. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Wells Fargo & Company raised their target price on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, May 14th. Barclays upped their price target on shares of Bath & Body Works from $31.00 to $35.00 and gave the company an "equal weight" rating in a report on Tuesday. Morgan Stanley dropped their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. Finally, The Goldman Sachs Group decreased their price objective on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $42.56.

Bath & Body Works Stock Down 3.5%

Shares of BBWI traded down $1.11 during trading hours on Wednesday, hitting $30.27. The company had a trading volume of 4,248,822 shares, compared to its average volume of 4,889,594. The firm has a market cap of $6.45 billion, a P/E ratio of 7.38, a P/E/G ratio of 0.92 and a beta of 1.87. The stock's 50 day moving average price is $30.22 and its 200 day moving average price is $34.00. Bath & Body Works has a 52-week low of $24.96 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%.

Bath & Body Works declared that its Board of Directors has authorized a stock buyback program on Thursday, February 27th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, June 6th. This represents a $0.80 annualized dividend and a yield of 2.64%. Bath & Body Works's payout ratio is 21.98%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in BBWI. Golden State Wealth Management LLC bought a new stake in Bath & Body Works during the fourth quarter worth about $26,000. SRS Capital Advisors Inc. boosted its stake in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. SVB Wealth LLC bought a new stake in Bath & Body Works during the first quarter valued at approximately $35,000. Finally, Geneos Wealth Management Inc. increased its holdings in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after buying an additional 801 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.